Twitter Beğeni Hilesi

Off to a great start! Well-organized pre-ASCO SARC meeting. Always important to listen to very insightful and driven sarcoma colleagues from across the world. Excited for #asco2024 presentations, ideas, and projects to come. Moffitt Cancer Center ASCO #sarcoma

Stop by the #sarcoma session at #ASCO24 today from 3pm-6pm CDT and listen to Dr. Patrick Grohar present SARC037. #ASCO2024 #ASCO #EwingsSarcoma #ClinicalTrials

Stop by the #sarcoma session at #ASCO24 today from 3pm-6pm CDT and listen to David Kirsch, MD, PhD present SARC032. #ASCO2024 #sarcoma #ClinicalTrials #SARCtrials

Come by the #ASCO24 #sarcoma session from 3-6pm CDT today and listen to the oral presentations of SARC032 and SARC037. #ASCO #ASCO2024 #sarcoma #SARCtrials #ClinicalTrials

#ASCO24 #sarcoma Pembrolizumab + preoperative radiotheraoy followed by adjuvant Pembrolizumab is new standard of care for UPS and Liposarcoma - HR 0.5 for distant metastasis-free survival Impressive results!! SARC

SARC032 establishes benefit of #pembrolizumab with pretreatment #radiation in #UPS and #LPS. 🎊congrats SARC and Dr. Kirsch ✅international phase 3 ✅143 pts 1:1 RT vs RT+pembrolizumab ✅2 year DFS 72.5% vs 54.5% 🤔greater benefit in grade 3 tumors? #ASCO24 #sarcoma

Stellar presentation David Kirsch, MD, PhD First trial on adding IO in #sarcoma #neoadjuvant #adjuavnt pembrolizumab to preop RT and surgery to >5cm G2/3 pleomorphic sarcoma/DDLiposarcoma improved disease free survival HR 0.57, 2yrDFS 55% to 73%. SARC Australia and New Zealand Sarcoma Association

Your donation dollars in action! 🙌A #StandUpToCancer-funded #research team unveiled an exciting #clinicaltrial breakthrough that reduces risk of #cancer relapse by 43% – for 2 of the most common types of soft tissue #sarcoma in adults, 2 years after treatment. Learn more:

It was a privilege to lead SU2C-SARC032 and present results at #ASCO2024. The trial was the result of the work of so many including Richard Riedel Yvonne Mowery Angela Hong & many other investigators

Groundbreaking results with inpressive DFS improvement from #immunotherapy (and #radiotherapy!) in subset of #sarcoma by David Kirsch, MD, PhD SARC #ASCO24 #radonc OncoAlert

Dr. Patrick Grohar presenting SARC037 data at #ASCO24. #sarcoma #EwingsSarcoma #ASCO2024 #SARCtrials

Be sure to follow #SARCTalk on Youtube, Spotify, or Apple to never miss an episode of our podcast. #sarcoma #SARCTrials #podcast

The newest #SARCtalk features two members from our Research Advocacy Council: Carolyn Dewalt and Val Stevenson. These two discuss their journey into #sarcoma advocacy and their efforts in spreading sarcoma awareness. #SarcomaAwarenessMonth Listen now: open.spotify.com/episode/1i0KS8…

July is #SarcomaAwarenessMonth! Today is wear yellow day showing support for #sarcoma patients & families. Are you wearing yellow today? We'd love to see a picture in the comments! #SARCtrials #WearYellowDay

#SARCtrials is honored to sponsor the SARC032 trial and extends special thanks to our partners Stand Up To Cancer, Merck, David Kirsch, MD, PhD, and many more. We are thrilled about this significant research advancement. #SarcomaAwarenessMonth #sarcoma #clinicaltrials

Pictured here at the #SARCtrials Semi-Annual Meeting at #CTOS this past November, Dr. Chris Fletcher has had an astounding impact on #sarcoma research and the sarcoma community. We are saddened to learn of his passing and are grateful for his amazing contributions.

The latest #SARCTalk features Brian Crompton speaking on the research his laboratory team is doing in the area of proteomic and genomic technologies to enhance the comprehension of #cancer biology and more. Listen now on Spotify: open.spotify.com/episode/5jB9kH… #sarcoma #SARCTrials

Join Neeta Somaiah, MD and Andrew Wagner, MD PhD on October 11th at 12pm CDT for a dedifferentiated #liposarcoma #MedEd in collaboration with PeerView. Register now: bit.ly/SARC2024T #sarcoma #SARCtrials

SARC044 is a Phase 2 trial investigating bezuclastinib in combination w/sunitinib in GIST patients who have previously progressed on sunitinib monotherapy. Learn more about eligibility: bit.ly/4fOupg1 #clinicaltrialsWednesday #advancedGIST #ThrivingTogether SARC

The latest #SARCTalk episode highlights Angela Hong discussing international clinical trials, SARC032, and more. #sarcoma #SARCTrials #clinicalresearch Listen here: open.spotify.com/episode/4RQxBD…